BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3544343)

  • 1. Detection of IgA dominant immune complexes on peripheral blood lymphocytes in patients with IgA nephropathy.
    Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Mar; 11(1):13-7. PubMed ID: 3544343
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
    Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
    Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
    Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
    Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
    Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
    Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
    [No Abstract]   [Full Text] [Related]  

  • 5. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
    Muda AO; Feriozzi S; Rahimi S; Faraggiana T
    J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IgA1-dominant immune complexes in peripheral blood polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy.
    Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
    Nephron; 1984; 37(2):137-9. PubMed ID: 6374482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in IgA nephropathy (Berger's disease).
    Stachura I
    Pathol Annu; 1983; 18 Pt 2():295-314. PubMed ID: 6232491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunochemical studies in glomerulonephritis with mesangial immunoglobulin A precipitation].
    Kiperova B; Nikolov K; Baleva M; Dzherasi R; Krŭsteva R
    Vutr Boles; 1988; 27(4):36-40. PubMed ID: 3213023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberration of B and T cell subsets in patients with IgA nephropathy and membranous nephropathy.
    Suga T; Endoh M; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1984 Jun; 9(2):95-101. PubMed ID: 6398930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IgA nephropathy (Berger's disease)].
    Romoşan I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(1):19-29. PubMed ID: 2861634
    [No Abstract]   [Full Text] [Related]  

  • 11. Disturbances of IgA immune regulation in lymphocytes from mucosae and peripheral blood in patients with IgA nephropathy.
    Garcia-Hoyo R; Egido J; Lozano L; de Nicolas R; Hernando L
    Semin Nephrol; 1987 Dec; 7(4):301-5. PubMed ID: 3502191
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double immunofluorescence studies on IgA-associated immune-complexes in glomerular deposits in patients with IgA nephropathy.
    Tomino Y; Nomoto Y; Endoh M; Sakai H; Arimori S
    Tokai J Exp Clin Med; 1980 Apr; 5(2):147-9. PubMed ID: 6998050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA nephropathy: perspectives on pathogenesis and classification.
    Emancipator SN; Gallo GR; Lamm ME
    Clin Nephrol; 1985 Oct; 24(4):161-79. PubMed ID: 3905099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IgG, IgM, and C3 in experimental murine IgA nephropathy.
    Emancipator SN; Lamm ME
    Semin Nephrol; 1987 Dec; 7(4):286-8. PubMed ID: 3328245
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
    Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
    J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
    Sinico RA; Fornasieri A; Maldifassi P; Colasanti G; D'Amico G
    Clin Nephrol; 1988 Oct; 30(4):182-6. PubMed ID: 3214964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoelectron microscopic studies of IgA nephropathy in children].
    Tanaka M
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):83-93. PubMed ID: 3699683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions.
    Mestecky J; Tomana M; Czerkinsky C; Tarkowski A; Matsuda S; Waldo FB; Moldoveanu Z; Julian BA; Galla JH; Russell MW
    Semin Nephrol; 1987 Dec; 7(4):332-5. PubMed ID: 3328246
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.